Cardiac Ablation Clinical Trials

Clinical trials related to Cardiac Ablation Procedure

Anatomical Navigation for Guided Electrophysiology in AFL and AFib

Status: Recruiting
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The objective of the study is to collect data on the use of the VERAFEYE Anatomical Guidance System in adult patients indicated to undergo a catheter ablation procedure for the treatment of Atrial Flutter (AFL), paroxysmal AF (PAF) or persistent AF (perAF). The study will collect specific information on management of AFL/AF ablation procedures with the commercial VERAFEYE Anatomical Guidance System including but not limited to acute procedural success , and how the VERAFEYE Anatomical Guidance System is used overall. Results from this study may be used to guide development and refinement the VERAFEYE Anatomical Guidance System.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• IC1: Subject is at least 18 years of age at the time of consent

• IC2: Subject is scheduled to undergo a catheter-ablation procedure to treat AFL/AF (\*according to current international and local guidelines and per physician discretion)

• IC3: Subject is able to understand and willing to provide written informed consent

• IC4: Subject is able and willing to complete all study assessments associated with this clinical study at an approved clinical study site

Contact Information
Primary
Alisa Komleva
alisa.komleva@lumavision.com
0894352047
Backup
Elke Sommerijns
Elke.sommerijns@lumavision.com
+32 479 76 71 56
Time Frame
Start Date: 2026-01-29
Estimated Completion Date: 2026-10-01
Participants
Target number of participants: 50
Treatments
Experimental: Atrial Fibrillation and Atrial Flutter arm
Subjects entitled to undergo a catheter-based ablation treatment for typical atrial flutter and/or atrial fibrillation
Related Therapeutic Areas
Sponsors
Leads: LUMA Vision Ltd.

This content was sourced from clinicaltrials.gov